FRESENIUS KABI NORGE, AS ,   Norway

An antiparkinsonian agent (dopamine precursor + decarboxylase peripheral inhibitor)
Gel for intestinal administration, 20 mg / ml + 5 mg / ml.


Antibiotic-oxazolidinone

Solution for infusion, 2 mg / ml.